Home
About Us
Certificate course in CRM
CRM Spotlight Buzz
CRM Live Events
Top 10 Papers
Contact
Home
About Us
Course
CRM Spotlight Buzz
CRM Live Events
Contact
Login
Join
Login
Join
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
22 February 2024
Posted in
Top 10 Papers voted by ESC for 2023 in Cardio Metabolic
«
Previous
Next
»